Current reports

Current report No. 7/2021 – The recommendation of the National Centre for Research and Development to co-fund a project for an inhaled drug candidate for the treatment of inflammatory and fibrotic lung diseases, including COVID-19 complications

2021-02-10

Current report No. 6/2021 – Completion of a phase IA clinical trial of a drug based on an innovative JAK/ROCK inhibitor – CPL 409116

2021-02-09

Current report No. 6/2021 – Completion of a phase IA clinical trial of a drug based on an innovative JAK/ROCK inhibitor – CPL 409116

2021-02-09

Current report No. 3/2021 – Obtaining a patent for GPR40 receptor agonists and their use in T2D treatment in the US

2021-01-21

Current report No. 2/2021 – The National Centre for Research and Development recommended co-funding of the project dedicated to the development of a drug based on GPR40 receptor agonists in the treatment of neuropathic pain

2021-01-18

Current report No. 1/2021 – Positive results of the phase II clinical trial on Celon Pharma’s DPI esketamine in bipolar treatment-resistant depression [03KET2018]

2021-01-08